Ashley Argiras on scaling quality in a platform biotech

In today’s episode I was joined by Ashley Argiras, VP of Quality at Recursion.I really wanted to speak to Ashley because she’s helping redefine what quality leadership looks like in a tech-enabled, platform biotech - and she’s doing it by shifting how people think, not just how they work.Ashley’s journey into science started in high school - not in a lab, but making ice cream during chemistry class. That moment sparked a lifelong curiosity that took her to Indiana University, and eventually into clinical research. She began her career as a CRA at Eli Lilly, where she visited trial sites and became the first line of quality, working hands-on with investigators to ensure patient safety and protocol integrity.That experience gave her a real-world understanding of what quality means at the ground level, and it’s shaped the way she leads today: rooted in purpose, driven by questions, and always looking for better ways to serve patients.We talk about the following:🎙️ How quality supports speed in a platform biotech🎙️ Ashley’s early career in clinical trials and where it all began🎙️ Teaching teams to ask better questions, not follow checklists🎙️ What “inspection ready” really means in a modern organisation🎙️ Why judgment and empowerment are better than policy and policing🎙️ How Ashley thinks about org structure during scale-up🎙️ Leading with listening (and learning to talk less as a VP)🎙️ Avoiding the bottleneck trap as a quality leader🎙️ Building a safe space for decisions - even if they’re wrong🎙️ Lessons in growing from tactical QA to strategic leadershipAshley is a sharp, thoughtful leader proving that real quality leadership starts with having the right mindset.Thank you, Ashley, for sharing your incredible journey.Hope everyone enjoys the show!